Vertex Pharmaceuticals (NASDAQ:VRTX) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Vertex Pharmaceuticals beat estimated earnings by 2.43%, reporting an EPS of $3.37 versus an estimate of $3.29, which did not surprise analysts.
Revenue was up $445.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.48, which was followed by a 4.23% increase in the share price the next day.
Here’s a look at Vertex Pharmaceuticals’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 3.08 | 2.28 | 2.69 | 2.59 |
| EPS Actual | 3.56 | 3.11 | 2.98 | 2.51 |
| Revenue Estimate | 1.86B | 1.72B | 1.66B | 1.58B |
| Revenue Actual | 1.98B | 1.79B | 1.72B | 1.63B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
